Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance.
First and second generation antipsychotics (FGAs and SGAs) ameliorate psychotic symptoms of schizophrenia, however, their chronic effects on information processing and memory function (i.e. key determinants of long term functional outcome) are largely unknown. In this rodent study the effects of different time periods (ranging from 2 weeks to 6 months) of oral treatment with the FGA, haloperidol (2.0 mg/kg/day), or the SGA, risperidone (2.5 mg/kg/day) on a water maze repeated acquisition procedure, the levels of nerve growth factor receptors, and two important cholinergic proteins, the vesicular acetylcholine transporter and the high affinity choline transporter were evaluated. The effects of the antipsychotics on a spontaneous novel object recognition procedure were also assessed during days 8-14 and 31-38 of treatment. Haloperidol (but not risperidone) was associated with impairments in water maze hidden platform trial performance at each of the time periods evaluated up to 45 days, but not when tested during days 83-90. In contrast, risperidone did not impair water maze task performance at the early time periods and it was actually associated with improved performance during the 83-90 day period. Both antipsychotics, however, were associated with significant water maze impairments during the 174-180 day period. Further, haloperidol was associated with decrements in short delay performance in the spontaneous novel object recognition task during both the 8-14 and 31-38 day periods of treatment, while risperidone was associated with short delay impairment during the 31-38 day time period. Both antipsychotics were also associated with time dependent alterations in the vesicular acetylcholine transporter, the high affinity choline transporter, as well as tyrosine kinase A, and p75 neurotrophin receptors in specific brain regions. These data from rats support the notion that while risperidone may hold some advantages over haloperidol, both antipsychotics can produce time-dependent alterations in neurotrophin receptors and cholinergic proteins as well as impairments in the performance of tasks designed to assess spatial learning and episodic memory.
Terry
A V
AV
Department of Pharmacology and Toxicology, CB-3618, Medical College of Georgia, 1120 Fifteenth Street, Augusta, GA 30912-2300, USA. aterry@mail.mcg.edu
Gearhart
D A
DA
Warner
S E
SE
Zhang
G
G
Bartlett
M G
MG
Middlemore
M-L
ML
Beck
W D
WD
Mahadik
S P
SP
Waller
J L
JL
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D006220:Haloperidol / Q000494:pharmacology*; D018737:Hand Strength / Q000502:physiology; D006624:Hippocampus / Q000187:drug effects; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D026901:Membrane Transport Proteins / Q000378:metabolism; D008568:Memory / Q000187:drug effects*; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D010275:Parasympathetic Nervous System / Q000166:cytology / Q000187:drug effects*; D004856:Postural Balance / Q000187:drug effects; D011597:Psychomotor Performance / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D020800:Receptor, Nerve Growth Factor / Q000096:biosynthesis; D020917:Receptor, trkA / Q000378:metabolism; D017475:Receptors, Nerve Growth Factor / Q000096:biosynthesis*; D021641:Recognition, Psychology / Q000187:drug effects; D018967:Risperidone / Q000494:pharmacology*; D050494:Vesicular Acetylcholine Transport Proteins / Q000378:metabolism
D014150:Antipsychotic Agents; D026901:Membrane Transport Proteins; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor; D050494:Vesicular Acetylcholine Transport Proteins; C065637:choline transporter; D020917:Receptor, trkA; D006220:Haloperidol; D018967:Risperidone